A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/15/2011	US20110305698 Treating Breast Cancer and Inhibiting Cancer-Associated Bone loss with Anti-IL-20 Antibody
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305696 anti-serum albumin binding variants
12/15/2011	US20110305695 Wnt Antagonists and Methods of Treatment and Screening
12/15/2011	US20110305694 Multivalent and/or multispecific rankl-binding constructs
12/15/2011	US20110305693 Anitigen-binding constructs
12/15/2011	US20110305692 Antigen-binding contructs
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305690 Antitumor combinations containing antibodies recognizing specifically cd38 and cyclophosphamide
12/15/2011	US20110305689 Treatment of chronic inflammatory respiratory disorders
12/15/2011	US20110305688 New virulence factors of streptococcus pneumoniae
12/15/2011	US20110305687 Anti-fgfr2 antibodies
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305685 Supramolecular approach for preparation of size controllable nanoparticles
12/15/2011	US20110305684 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
12/15/2011	US20110305666 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
12/15/2011	US20110305664 Novel vaccines against multiple subtypes of influenza virus
12/15/2011	US20110305640 Method to treat psoriasis and other hyperproliferative skin disorders
12/15/2011	US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
12/15/2011	US20110305631 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
12/15/2011	US20110305630 Misfolded proteins in cancer treatment and diagnosis
12/15/2011	US20110305629 Anti-Alpha v Beta 6 Antibodies and Uses Thereof
12/15/2011	DE112009002431T5 Anwendung von Fc-Fragmenten von Immunglobulin G als Antigen zur Behandlung von rheumatoider Arthritis, Behandlungsmittel und Verfahren zur Behandlung Application of Fc fragments of immunoglobulin G as the antigen for the treatment of rheumatoid arthritis, treatment agents and methods for treating
12/15/2011	CA2814155A1 Anti-tim-3 antibody
12/15/2011	CA2802102A1 Cgrp antibodies
12/15/2011	CA2802023A1 Trisaccharide derivates, and their use as adjuvants
12/15/2011	CA2801984A1 Novel process
12/15/2011	CA2801983A1 Novel process
12/15/2011	CA2801922A1 Multivalent glycopeptide constructs and uses thereof
12/15/2011	CA2800830A1 Vaccine and methods to reduce campylobacter infection
12/15/2011	CA2800774A1 Ige ch3 peptide vaccine
12/15/2011	CA2800026A1 Tear lipocalin muteins binding il-4 r alpha
12/15/2011	CA2799076A1 Anti-tumor composition
12/15/2011	CA2798837A1 Her-2 peptides and vaccines
12/14/2011	EP2395099A2 Amino acid substituted molecules
12/14/2011	EP2395073A2 Drying process
12/14/2011	EP2395026A2 Method for improving antibody
12/14/2011	EP2395024A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395023A2 Modified antigen binding molecules with altered cell signaling activity
12/14/2011	EP2395022A1 Lingo binding molecules and pharmaceutical use thereof
12/14/2011	EP2395021A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/14/2011	EP2395020A2 IL-18 binding proteins
12/14/2011	EP2395019A1 Remedy for chronic inflammation and antibody to be used therein
12/14/2011	EP2395018A1 Human binding molecules having killing activity against staphylococci and uses thereof
12/14/2011	EP2395013A2 Proteins comprising conserved regions of Neisseria meningitidis surface antigen NhhA
12/14/2011	EP2394662A2 Methods and compositions for treating and preventing disease associated with AlphavBeta5 intergrin
12/14/2011	EP2394661A1 Sp35 antibodies and uses thereof
12/14/2011	EP2394660A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/14/2011	EP2394659A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
12/14/2011	EP2394658A2 Passive immunization against clostridium difficile disease
12/14/2011	EP2394657A1 Vaccine nanotechnology
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394652A2 Methods and compositions for treating tumors and metastatic disease
12/14/2011	EP2394650A1 Use of resiquimod for the treatment of cutaneous metastases
12/14/2011	EP2393836A1 Sam-6 variants, target and methods of use
12/14/2011	EP2393835A2 Pd-1 antibodies and pd-l1 antibodies and uses thereof
12/14/2011	EP2393832A1 Truncated cystine-knot proteins
12/14/2011	EP2393830A1 Grass peptides for vaccine
12/14/2011	EP2393824A2 Plasmodium malariae and plasmodium ovale genes and uses thereof
12/14/2011	EP2393515A1 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
12/14/2011	EP2393514A1 Dual inhibition of immunophilin/cyclophilin and emmprin immunoglobulin receptor superfamily members
12/14/2011	EP2393513A2 Methods of treating vascular lesions
12/14/2011	EP2393512A1 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
12/14/2011	EP2393511A2 Contiguous overlapping peptides for treatment of birch pollen allergy
12/14/2011	EP2393510A1 Novel gp41 antigens
12/14/2011	EP2393509A1 Splitting gp41
12/14/2011	EP2393497A1 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
12/14/2011	EP2393496A1 Improved vaccines for human papilloma virus and methods for using the same
12/14/2011	EP2393364A1 Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor
12/14/2011	EP2184072B1 Production of an homogeneous vaccine preparation for cancer treatment
12/14/2011	EP2041177B1 High affinity antibodies to human il-6 receptor
12/14/2011	EP1896063B1 Immunogenic composition
12/14/2011	EP1740616B1 Anti-tfr antibody.
12/14/2011	EP1680499B1 Modulation of angiogenesis by bartonella henselae
12/14/2011	EP1641492B1 Controlled platelet activation to monitor therapy of adp antagonists
12/14/2011	CN1871355B 从cDNA中回收非节段性负链RNA病毒的改进方法 Recovering an improved method of non-segmental negative-strand RNA viruses from cDNA in
12/14/2011	CN1720060B 人乳头瘤病毒多肽和免疫原性组合物 HPV polypeptides and immunogenic compositions
12/14/2011	CN1582337B 丙型肝炎病毒疫苗 Hepatitis C virus vaccine
12/14/2011	CN102282268A eIF3m在癌症的诊断和治疗中的用途 eIF3m use in the diagnosis and treatment of cancer
12/14/2011	CN102282253A 狂犬病病毒的纯化方法 Purification of rabies virus
12/14/2011	CN102282173A 用于治疗骨丢失的方法和组合物 Methods for treating bone loss and compositions
12/14/2011	CN102281903A 降低大分子在生理条件下聚集的方法和配方 Macromolecules under physiological conditions to reduce aggregation methods and formulations
12/14/2011	CN102281902A 用于减少大分子在生理条件下聚集的方法和制剂 For reducing aggregation under physiological conditions macromolecules methods and formulations
12/14/2011	CN102281901A 治疗性蛋白质制剂 Therapeutic protein preparations
12/14/2011	CN102281898A Il-20拮抗剂在治疗类风湿性关节炎和骨质疏松症中的应用 Il-20 antagonists in the treatment of rheumatoid arthritis and osteoporosis in
12/14/2011	CN102281897A 通过机械破坏表皮进行痘病毒载体的疫苗接种 Vaccination poxvirus vector by mechanical destruction epidermis
12/14/2011	CN102281896A 重组失活病毒载体疫苗 Inactivated recombinant viral vector vaccines
12/14/2011	CN102281895A 用于肠产毒性大肠杆菌导致的猪断奶后腹泻的疫苗 Vaccine for swine caused by enterotoxigenic Escherichia coli diarrhea in weaned
12/14/2011	CN102281894A 睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂 Sleep-related breathing hard awakening and snoring treatment and medicine
12/14/2011	CN102281893A 猪痢疾短螺旋体的疫苗株 Vaccine strains of Brachyspira hyodysenteriae
12/14/2011	CN102281892A 酿酒酵母线粒体核酸级分用于免疫刺激的用途 Saccharomyces cerevisiae mitochondrial nucleic acid fraction for the purpose of immune stimulation
12/14/2011	CN102281891A 白蛋白结合肽介导的疾病靶向 Albumin binding peptide-mediated diseases targeted
12/14/2011	CN102281884A 表达至少两种可变表面蛋白(vsp)的修饰原生动物,其疫苗及纯化方法、应用和免疫方法 Expression of at least two variable surface protein (vsp) modified protozoa, its vaccines and purification methods, applications and immunological methods
12/14/2011	CN102281880A 类Toll受体抑制剂在高胆固醇血症和高脂血症及相关疾病的预防和治疗中的用途 Class Toll receptor inhibitors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and related diseases in the use of
12/14/2011	CN102281867A 用于靶向树突细胞的组合物 For targeting dendritic cells in the composition
12/14/2011	CN102277431A 人颅内生殖细胞肿瘤标志物基因hesrg的应用方法 Intracranial germ cell tumor marker gene hesrg application method
12/14/2011	CN102277384A 一种psa重组腺相关病毒载体及其构建方法与应用 One kind psa recombinant adeno-associated virus vector and its construction method and application
12/14/2011	CN102277374A 一种鸡传染性法氏囊病基因工程亚单位疫苗的制备和应用 An IBD genetic engineering subunit vaccine preparation and application

1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 1823